Bisphosphonates target multiple sites in both cis- and trans-prenyltransferases
Guo, R.T., Cao, R., Liang, P.H., Ko, T.P., Chang, T.H., Hudock, M.P., Jeng, W.Y., Chen, C.K.-M., Zhang, Y., Song, Y., Kuo, C.J., Yin, F., Oldfield, E., Wang, A.H.-J.(2007) Proc Natl Acad Sci U S A 104: 10022-10027
- PubMed: 17535895 
- DOI: https://doi.org/10.1073/pnas.0702254104
- Primary Citation of Related Structures:  
2E8T, 2E8U, 2E8V, 2E8W, 2E8X, 2E90, 2E91, 2E92, 2E93, 2E94, 2E95, 2E98, 2E99, 2E9A, 2E9C, 2E9D - PubMed Abstract: 
Bisphosphonate drugs (e.g., Fosamax and Zometa) are thought to act primarily by inhibiting farnesyl diphosphate synthase (FPPS), resulting in decreased prenylation of small GTPases. Here, we show that some bisphosphonates can also inhibit geranylgeranyl diphosphate synthase (GGPPS), as well as undecaprenyl diphosphate synthase (UPPS), a cis-prenyltransferase of interest as a target for antibacterial therapy ...